Claus Belka

Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.

U. Dafni, D. de Ruysscher, D. Ruysscher, 2019, Lung cancer.

The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy

A. Afshar-Oromieh, S. Fanti, C. Zamboglou, 2023, European journal of nuclear medicine and molecular imaging.

HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

A. Abdollahi, I. Tinhofer, S. Pigorsch, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts.

I. Tinhofer, S. Pigorsch, F. Lohaus, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review

S. Corradini, P. Rogowski, J. Knoth, 2024, Cancers.

Multitask Learning with Convolutional Neural Networks and Vision Transformers Can Improve Outcome Prediction for Head and Neck Cancer Patients

I. Tinhofer, A. Zwanenburg, Karoline Leger, 2023, Cancers.

Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.

W. Weichert, V. Budach, J. Debus, 2016, European journal of cancer.

First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis

C. Eze, F. Manapov, A. Tufman, 2023, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].